Hansa Biopharma AB (publ) (STO: HNSA)
Sweden
· Delayed Price · Currency is SEK 32.10
-1.36 (-4.06%)
Jan 20, 2025, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 2.18 billion as of January 21, 2025. Its market cap has increased by 59.65% in one year.
Market Cap
2.18B
Enterprise Value
2.58B
Revenue
189.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.10
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 2.18B, an increase of 6,987.83%. That is a compound annual growth rate of 28.96%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 113.61B |
| Getinge AB | 52.49B |
| Sectra AB | 48.16B |
| Camurus AB | 33.40B |
| Medicover AB | 30.10B |
| Vitrolife AB | 28.16B |
| Bonesupport Holding AB | 24.57B |
| Elekta AB | 24.22B |